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     In today’s fast growing world of health care, the volume of drug information 
needed to provide competent care to patients is overwhelming. On average, health care 
professionals have two informational needs for every three patients seen which are either 
related to diagnosis or treatment. Therefore, seeking appropriate drug information to 
answer these informational needs is an important and valuable element of health care. 
Drug information can be obtained from different sources. Traditional sources like books, 
journals, meeting with colleagues, physicians’ desk reference (PDR) or modern sources 
like the Internet (Google, Wikipedia), medical databases and medical literature indices. 
The information so obtained from these sources helps health care professionals to fill the 
gap in knowledge on new drugs and improve patient care. 
Therefore, the purpose of this study is (1) to identify health care professionals 
(HCPs) reported frequencies of use for different drug information sources in the 
University of Utah Community Clinics to obtain drug information (2) to descriptively 
find out of if there existed a difference between clinicians and pharmacists in their drug 
information seeking behaviors. 
The study design was cross-sectional and utilized a survey questionnaire to 
capture the drug information-seeking behaviors among health care professionals The 
Mission Based Survey Management tool was used to send out the surveys.
iv 
The survey response rate was 55%. Clinicians most frequently reported to use drug 
information databases (46%) followed by personal digital assistants (PDAs) (23%) and 
electronic sources (18%) while pharmacists most frequently reported to use drug 
information databases (78%)  followed by electronic sources (28%) and medical 
literature indices (19%). Clinicians were more likely to use PDAs to access drug 
information than pharmacists which could be due to portability and easier access to drug 
information via PDAs at point of care. 
Based on the results obtained from the study, it is reasonable to conclude that 
when clinicians and pharmacists were given a wide range of sources to choose from to 
seek drug information, most clinicians and pharmacist preferred to use drug information 
databases to obtain new drug information as compared to the traditional sources like 
books, journals and colleagues. Modern and improved technological sources of drug 
information have taken the place of traditional sources of drug information, reducing 
health care professionals’ trips to the library or to the printed medical journals and books, 
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Health care professionals face many challenges in keeping their practice current. 
Health care professionals cannot practice high quality medicine without constantly 
updating their clinical knowledge to help improve patient care. With the broad scope of 
family practice, most physicians and nurses are faced with informational needs related to 
therapy or diagnosis, while pharmacists are faced with drug-related informational needs. 
Thus, seeking appropriate drug information is very important for health care 
professionals. There are numerous ways in which health care professionals can access 
drug information. These include traditional sources like consultations with colleagues, 
enrollment in professional organizations, drug reference manuals, books, protocol 
manuals and more modern sources like personal digital assistants (PDAs), medical 
databases, and medical literature indices.1,2,4,5,6 Meetings with sales representatives from 
pharmaceutical companies and Internet searches are also helpful in seeking appropriate 
drug information.3,8,10 The information acquired from these sources keeps health care 
professionals up-to-date on the latest medications available to treat various diseases, 
helps them to resolve issues surrounding uncertainties and evidence, helps to improve 





Most recent studies done in the early 2000s focus on one particular source (e.g. 
PDAs or Internet or online databases) and one type of health care professional, describing 
the associated benefits and frequency of use of the source of information. It does not 
allow for comparison with other sources.  
Therefore, the purpose of this study is (1) to identify health care professionals’ 
(HCPs) reported frequencies of use of different drug information sources in the 
University of Utah Community Clinics to obtain drug information and (2) to descriptively 





REVIEW OF LITERATURE 
2.1 Why Is It Important to Obtain New Drug Information? 
     Seeking drug information is an important clinician activity in health care. 
Seeking this information is essential for problem-solving and is an important step in the 
complex process that begins with identifying the question and goes all the way to finding 
the best possible answer. Some commonly identified categories of informational needs 
are related to drug therapy, which is required for 26%-40% of patients and diagnosis, 
which is required for 38%-53% of patients. 1,7,8,9,11,12, 19  On average, physicians and 
nurses had two informational needs for every three patients seen related to either 
treatment or diagnosis. Seeking drug information appropriately to answer these questions 
related to treatment or diagnosis eventually helps to improve patient care by reducing 
medication errors.17  Seeking drug information also helps to keep health care 
professionals abreast of the latest happenings in the drug world. Furthermore, it helps 
health care professionals in assisting their own diagnosis, following up on treatments 





2.2 Commonly Used Sources to Obtain Drug Information 
as Reported in Literature by Different 
Health Care Professionals 
Health care professionals acquire drug information from a variety of sources.  
Sources can be classified as commercial, which include drug company representatives, 
drug advertisement and physicians’ drug reference (PDR) and noncommercial, which 
include text books, medical letters, journal articles, professional meetings, hospital 
pharmacists, colleagues and community pharmacists. They could also be classified as 
written sources, which include books, journals, medical letters, drug company 
advertisements and physicians’ drug reference and oral sources, which include 
professional meetings, hospital pharmacists, colleagues and community pharmacists. 
2.2.1 Physicians’ Drug Information-Seeking 
Behaviors Over Time 
 In the 70s, 80s and early 90s, physicians most frequently used books and journals 
to seek drug information followed by meeting with colleagues. As times changed and 
technology evolved, physicians began using the Internet and personal digital assistants 
(PDAs) as a source of drug information.  
The investigators of a study done in 1978 with physicians on informational needs 
of physicians 2  concluded that most physicians needed more information on new drugs 
and physicians most frequently used journals followed by colleagues and books to seek 
drug information. Authors of a meta-analysis conducted with physicians in the United 
States (US) and Canada in 1997 on drug information sources used 3 found that physicians 
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most frequently referred to books and journals. In addition to these, physicians also 
consulted with colleagues and met with SRs to obtain the requisite drug information. 
Authors of another study conducted with general practitioners (GPs) in 1980 in the UK 
on usage of information sources 4 found that industrial sources such as sales 
representatives, drug advertisements and drug sheet compendia etc. were used to seek 
new drug information while professional sources such as books, journal and colleagues 
were used to evaluate the information obtained. Older single practice GPs were more 
likely to use industrial information sources.  Investigators of another study done with 
physicians in 1980 on health care professionals’ information habits and needs 5 concluded 
that medical literature (i.e. personal references, journals and books) were the most 
frequently used sources of drug information. Colleagues were the next most used source 
of information among physicians. Sales representatives were used as a source of 
information but only among health care professionals with more professional experience. 
The authors of a study done with physicians in 1986 on the ten most frequently used 
sources of information6 concluded that physician’s desk reference (PDR) was the most 
accessible and frequently used source of information followed by books, journals, 
professional meeting, colleagues, hospital pharmacists and drug company representatives. 
The investigators also said that drug company representatives were used more frequently 
by physicians than books, journals, professional colleagues and pharmacists as a source 
of information. Noncommercial sources of information were less frequently used than 
commercial sources of information. Written sources of new drug information were more 
frequently used than oral sources of new drug information by physicians. Among the 
older physicians, with more than 15 years of practice, sales representatives and 
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community pharmacists were a source of new drug information.  A number of other 
studies that looked at physicians’ informational needs and sources used to obtain drug 
information in the mid-1990s 7, 8, 9 revealed that physicians most frequently used 
colleagues as a source for drug information followed by books and journals. Physicians 
preferred print sources of information. 9 
Traditionally, physicians acquired drug information from books, journals and 
colleagues but the information-seeking behaviors are evolving as a result of increased 
practice demand, easier access to the Internet, and ever increasing clinical evidence. 
More than half the family physicians use the Internet to seek drug information. A survey 
by the American Medical Association demonstrated that the use of the Internet has grown 
from 21% in 1997 to 78% in 2001.10 The reasons to use the Internet as a source of 
information were to enhance patient care, update knowledge and to inform clinical 
decisions.11 
A study of general practitioners (GPs) through a survey in 2002 12 showed that 
48.6% of the physicians used the Internet to get information on rare diseases to help in 
diagnosis or to follow up on a diagnosis made by specialists, for updates on common 
diseases and for conditions not responding for common treatments. MEDLINE was the 
most commonly accessed source. The other frequently used search engines were Yahoo, 
Google and Alta Vista. GPs were more likely to search MEDLINE for patient-oriented 
material. Most GPs evaluated the information obtained from the Internet based on the 
reputation of the journal in which it was published.  Of the total respondents, 34% of the 
GPs evaluated the information based on the methods employed. Once again, textbooks 
were ranked as the most preferred source to obtain drug information, followed by 
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colleagues. Authors of another study with physicians on their information-seeking 
behaviors through a faxed survey in 2004 13 concluded that 59% of the physicians 
regularly access the Internet to seek clinical information and 73% of the physicians 
believe the Internet to be valuable and an important source of clinical information. 
Investigators of another study with physicians via a faxed survey in 200511 concluded 
that 89% of the physicians accessed the Internet to seek drug information to improve 
patient care, to make informed clinical decisions, to update their own knowledge or a 
blend of these purposes. In spite of the high usage of the Internet to seek drug 
information among physicians, they still preferred using journals and drug databases to 
obtain the required information in comparison to the Internet. 
With further advances in information technology and the emergence of Personal 
Digital Assistants (PDAs) since the late 1990s, family physicians shifted towards the use 
of PDAs to seek drug information. The overall adoption rates of PDAs is between 45%-
85%.16 The reason most commonly given for the use of PDAs was that it made drug 
information resources rapidly accessible at point of care. It improved patient care and 
reduced medical errors. 
Studies were done between 2000-2005 to evaluate the clinical use of PDAs 15, 16 
and benefits associated with the use of PDAs. 17 Authors from the study concluded by 
saying that ePocrates Rx (a comprehensive drug information guide that can be 
downloaded from the Internet) saved time required for drug information retrieval. PDAs 
could be easily incorporated into their usual workflow and improved their drug-related 
decision-making.15,17 Most family physicians (71%) were big adopters of PDAs compared 
to specialists. About 33% of hospital practicing pharmacists used PDAs either at home or 
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at work for similar reasons and purposes. 16 Physicians felt that the use of PDAs helped 
them to improve patient care and was a valuable tool in learning about new drugs. About 
61% of the physicians believed that the use of PDAs reduced preventable adverse drug 
events and medication errors by three times or more. 17 Authors of a meta-analysis study 
done among residents and medical students on the use of PDAs between 1993-200418, 19 
concluded that 60%-70% of the residents used PDAs for patient care. Resident 
physicians’ felt it was valuable in seeking the required information at the point of care. In 
spite of the high usage, many physicians’ preferred books and journals as a source of 
information. 19 
Thus, from all these studies mentioned above, it is reasonable to conclude that in 
recent times with advances in technology, physicians have begun using the Internet and  
PDAs as a source of drug information, but when physicians were asked their primary 
source of drug information, most physicians rated books and journals as their primary 
source for information.  
2.2.2 Nurse Practitioners’ Drug Information-Seeking 
Behaviors Over Time 
Nurse practitioners differed from physicians and pharmacists in usage of the 
different sources for drug information. Their informational needs were similar to 
physicians but the sources preferred to acquire that information varied from physicians. 
Human sources of information such as supervising physician, sales representatives and 
colleagues were preferred compared to print and online sources. 
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Evidence from a study done with nurse practitioners (NP) in a primary care 
setting by means of a survey and followed by an interview in 2003 showed that, on 
average, there were two informational needs for every three patients seen and they were 
related to treatment and diagnosis. 20 The investigators concluded that 63% of the NPs 
asked their supervising physicians about drug information, 61% used drug reference 
manuals and 51% of the NPs used books as a source of information.  Authors of another 
study done with clinical nurses through a survey in 2005 that consisted of questions, 
interviews and observations21 concluded that clinical nurses relied extensively on books 
for medical information. GPs and information from sales representatives were also 
valued. Almost 60% of clinical nurses and 38% of nurse students, respectively, preferred 
human sources of information rather than online sources. Other similar studies on nurses’ 
information-seeking behavior 22, 23 reported that nurses preferred human sources of 
information to text and online sources. Researchers of the study with community nurses 
done in July 200324 concluded that community nurses sought drug information primarily 
through journals, but also utilized sales representatives, community pharmacists, nurse 
specialists and GPs as a source of drug information. Other studies done to find out nurses’ 
use of the Internet and PDAs to seek drug information 25, 26 reported that the use of PDAs 
among nurses to seek drug information is limited. They preferred print sources instead.  
2.2.3 Pharmacists’ Drug Information-Seeking 
Behaviors Over Time 
          Pharmacists’ need for information was mostly restricted to drugs. They sought drug 
information through text books followed by use of web sites.27,28 Colleagues were very 
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rarely used as a source of drug information among pharmacists. The use of PDAs was 
also very limited among pharmacists. 
Investigators of a study done with pharmacists in hospitals and community 
pharmacies in 197827 concluded that both groups sought drug information from a narrow 
range of textbooks. Authors of another study done with pharmacists in Alabama in 2006 
28 concluded that drug facts and comparisons were most frequently used followed by 
PDR. The use of PDAs was low (19%) among the pharmacies. Authors of another study 
done with pharmacists via an online survey in Singapore 2009 on the drug information 
resources used 29 concluded that 82% of the pharmacists used reference text as a source of 
drug information. Twenty-three percent of the pharmacists reported to use web sites to 
seek drug information. Authors of another study done with pharmacists in 2005 on their 
perception about the pharmaceutical industry 30concluded that most pharmacists (58%) 
valued the information given by pharmaceutical sales representatives. 
2.3 Summary of the Background 
1. All heath care professionals are faced with drug information needs. Health 
care professionals are most frequently faced with drug informational needs 
related either to diagnosis or treatment of patients. 
2. In order to answer these drug information-related needs, health care 
professionals have access to a variety of drug information sources. These 
sources can be differentiated as commercial, which include drug company 
representatives, drug advertisement and physicians’ drug reference (PDR) and 
noncommercial, which include text books, medical letters, journal articles, 
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professional meetings, hospital pharmacists, colleagues and community 
pharmacists. They could also be classified as written sources, which include 
books, journals, medical letters, drug company advertisements and physician’s 
drug reference and oral sources, which include professional meetings, hospital 
pharmacists, colleagues and community pharmacists.  
3. Among the various sources of information available, physicians were more 
likely to use books, journals and meeting with colleagues as a source of drug 
information. Sales representatives were used as source of information only 
among physicians with greater experience. 
4.  But with the growth in the technological field and the presence of the Internet 
in the mid-1990s, physicians began using the Internet to seek drug 
information. There was growth in the use of Internet from 21% in 1997 to 
78% in 2001. Various search engines and medical databases were used for the 
purpose. Most physicians used MEDLINE to seek drug information with more 
than 59% of the physicians using the Internet. 
5. With the advent of personal digital assistants (PDAs) in the early 2000s, 
family physicians became early adopters of PDAs. More than half the family 
physicians use PDAs to seek drug information at the point of care. Physicians 
felt that the use of PDAs has improved their ability to make informed clinical 
decisions and reduce medical errors. They also felt drug information has 
become more accessible and specific information related to a particular drug 
could be retrieved in a matter of seconds. 
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6.  Nurses, on the other hand, preferred using books, journals, supervising 
physicians and sales representatives as a source for seeking new drug 
information. PDA use among nurses was very limited 
7. Pharmacists most frequently used textbooks to seek drug information 
followed by the use of the Internet. They also valued the information given to 
them by sales representatives.  
8. Previous research on drug information gathering largely predates PDAs and 
the Internet.  The recent research on drug information sources used by health 
care professionals focuses on one particular source such as PDAs or the 
Internet and does not allow for comparison with other sources. 
 Therefore, the purpose of this study is (1) to identify across the different sources 
of drug information available which sources of information are being used by health care 
professionals in the University of Utah Community Clinics to obtain new drug 
information (2) to descriptively find out if there existed a difference in the way 







This was a cross-sectional observational survey of sources of drug information.  
The goal of this small-scale study within the community clinics in the University of Utah 
was to determine from where health care professionals obtain drug information to 
improve clinical care provided to patients and stay updated on the latest drugs. This study 
also tried to descriptively identify if there exists a difference in the way health care 
professionals seek drug information.  
3.1  Study Setting 
 This study was conducted in the University of Utah Outpatient Community 













• South Jordan 
• Parkway 
3.2 Study Design 
This study was a cross-sectional analysis using an electronic survey tool. The 
questionnaire was created by adapting surveys from previous studies.3, 6, 13, 20 
Questions were formatted by using a combination of multiple choice, matrix questions 
and short answers.  
3.3 Study Subjects 
The study population included all the primary care providers within the 
community clinics. The primary care providers were primary care clinicians, nurse 
practitioners, pharmacists, physician assistants and resident clinicians. The survey was 
sent to all the above mentioned health care professionals within the participating clinics. 
There were about 57 clinicians, 62 pharmacists, 2 nurse practitioners, 9 physician 
assistants and 24 resident physicians within the community clinics who were surveyed. 
Since the total sample size was small (154), the study did not have enough power to 
detect difference between the groups. The results were reported quantitatively. The 
response rate for similar surveys done previously was between 35-80%. 6, 3, 20, 30 The 
lower range were for surveys that had just one follow-up while the higher range was for 
surveys that had multiple follow-ups, interviews and personal observation. For this study, 
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a response rate between 50%- 60% was expected, as the internal Utah Health Research 
Network (UHRN) email was used, which physicians, physician assistants, resident 
physicians and nurse practitioners accessed more often.  
3.4 Data Collection 
           The Mission Based Survey Management tool (MBM), which is an E-survey tool, 
was used to collect the data. The E-survey offers the following features: (i) allows the 
researcher to create a set of questions, (ii) makes the questions available to the study 
participants by sending them an email or sharing a URL and (iii) allows for viewing the 
responses to questions as and when they are answered. The UHRN internal email 
network was used to send out the surveys. 
3.5 Data Reporting 
 Once the survey was completed and the time period to fill out the surveys was 
over the MBM provided a brief report as well as a detailed report in the form of a word 
document. It also provided a PDF file with the raw data. An Excel spreadsheet was also 
provided in which each row represented one respondent and each column represented one 
question with answers from left to right on each row. From these data, graphs and tables 
were made that summarized the demographic information, the mean, standard deviation, 





3.6 Questionnaire Preparation 
The questionnaire was set up after an extensive literature review.31,32 The review 
included reading articles related to wording and formatting of the questionnaire for easy 
understanding by the participants. The articles also provided specific information 
regarding various styles for formatting the questions to obtain appropriate information 
related to the study question. In addition to the above information, the articles also 
provided in-depth knowledge on the common pit falls that should be avoided while 
developing and formatting the questionnaire. Within the questionnaire, every research 
aspect was a separate question that enabled the investigator to know the participants’ 
preference or perception for the different questions. Negatively worded questions were 
avoided to prevent participants from being biased. The scales used to measure the 
preference in the matrix questions are common Likert scales that have been used in a 
number of studies previously for easy understanding. 20, 31  
The first step after the above mentioned literature review was to develop the 
survey questions. For this study, the survey included three research questions with 26 
aspects. The three questions were related to sources of drug information, value of drug 
company sales representatives, impact of restrictions and alternatives preferred in 
absence of sales representatives.  Only the first question is addressed in this thesis. 
 With reference to Table 3.1, multiple choice questions were used for basic 
demographics such as age, sex, time in practice, time since graduation and location of 
practice. This information helped to describe the survey respondent characteristics. 
Matrix questions were used to identify and qualify preferences for the different sources 
used to obtain new drug information. The matrix questions in the questionnaire were  
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related to frequency of use of the different resources for making clinical decisions. The 
subquestion choices within these matrix questions were chosen based on previous 
literature findings for the most frequently used sources to obtain drug information and 
suggestions from health care professionals 3,6,13, 
The survey was tested by health care professionals including pharmacists and 
physicians. Feedback was incorporated into the revised questionnaire with the goal of 
optimizing the likelihood of obtaining the desired information. Feedback on the wording 
of the questions was provided by the committee members as well as other physicians. 
The questionnaire was designed to take 10 minutes, which was verified by the committee 
members and health care professionals. The questionnaire is presented in Appendix A. 
Once the questionnaire was created, applications were sent to the Institutional Review 
Board (IRB) and Utah Health Research Network (UHRN). The UHRN application was 
submitted online on Jan 9th 2009 and the approval was received on Jan 26th 2009. The 
Table 3.1- Description of Information Collected from the Questionnaire 
SR 
No 
Variable Type of variable 
1 Demographic Data  
 (a) Age Continuous Variable 
 (b) Sex Categorical Variable 
 (c) Years since complete training Continuous Variable 








Frequency of reported use of the different sources to obtain 
drug information and identify is there exists a difference in 
drug information seeking behavior 
Types and  frequencies of use of the different sources for 









IRB application was completed and sent online on Jan 20th 2009. The application number 
was IRB_00031881. The study was exempt, under 45 CFR 46.101(b), Category 2, from 
the Federal regulations governing human research and an email notifying the same was 
sent on Feb 3rd 2009. 
The second step after the questionnaire development, the IRB and UHRN 
approvals was to send out the questionnaire to the different health care professionals 
within the community clinics participating in the study. For this, the MBM List Builder 
application was used. In E-surveys, these lists are referred to as ‘Distribution Lists.’ For 
the purposes of this study, 2 distribution lists were created, a ‘Closed Distribution List’ 
and an ‘Open Access Distribution List.’  
The ‘Closed Distribution List’ would allow only health care professionals’ whose 
email addresses were known to participate. These email addresses were obtained through 
the University database, while the ‘Open Access Distribution Lists’ was for those health 
care professionals who wanted to answer the survey through their outlook email address, 
that was sent via the Utah Health Research Network (UHRN) email network.  
The third step after the distribution list was prepared was to set a campaign for the 
survey. In E-surveys, setting up a campaign involves setting up a time frame for the 
participants to answer the survey. For the purpose of this study, the time frame was “54 
days” i.e., March 6th 2009 - April 29th 2009. The campaign feature within the MBM tool 
allows the principal investigator to send reminders to the health care professionals who 
have not filled out the survey or who had not accessed the survey, thus assisting in 
regular and timely follow up. Once the campaign was activated, the researcher was not 
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allowed to make any changes to the questionnaire, ensuring that all the participants 
received the same questions. 
Once these three steps were in place, a cover letter indicating the purpose of the 
research was sent to all the participating health care professionals using the distribution 
lists as well as the UHRN internal email network. The letter explained the purpose of the 
survey and that a link or URL would be arriving in their email inboxes. Follow-up emails 
were sent twice in a span of 15 days, after which follow-up emails were sent every 4 days 
to only those health care professionals who had not accessed or answered the survey. 
This ensured that all of the participating health care professional received it and were 
aware of the research. Follow-up was done eight times via email. To improve the 
response rate, the principal investigator also attended three provider meetings and handed 
out the survey questionnaire in person, requesting health care providers to participate. 
Telephone follow-up calls were also made to the pharmacy sites within each clinic to 









4.1 Response Rate 
Out of the 154 surveys that were emailed, 85 (55%) responded. Of the 85 who 
responded, 35 were physicians, 7 were physician assistants [PA], 6 were resident 
physicians, 1 was a nurse practitioner [NP] and 36 were pharmacists. Response rates by 
health professional type are presented in Table 4.1. For the purpose of this study, 
physician assistants and nurse practitioners were grouped together with the physicians 
group. PA and NP were grouped together with the physicians group for the following 
reasons: 1) the sample size was too small to consider them as a separate group, 2) they 
performed similar functions (diagnosing the disease state of the patient or checking blood 
pressure or prescribing medicines for the disease state) and 3) they had similar 
respondent characteristics to the physicians. For this study, the group of physicians, NP 
and PA, was referred to as ‘Clinicians.’ Resident physicians were excluded as (1) they 
were part-time employees at the clinics and rotated among different specialties, (2) they 
were all in training, (3) they met with sales representatives too often (2-3 times a month) 





 employee status and (4) the count was too small to be considered as a separate group (6). 
Thus, for this study, the total number of clinicians was 43 and of pharmacists was 
36 with a response rate of 51%. 
4.2 Demographic Description of Health Care Professionals 
     A summary of the responder’s characteristics is shown in Table 4.2. Of the 79 
respondents, 43 were clinicians and 36 were pharmacists. Of the 43 clinicians, 17 (40%) 
were males and 26 (60%) were females while among the 36 pharmacists, 14 (39%) were 
males and 22 (61%) were females. The mean age (SD) for clinicians was 43.23 years 
(9.52) and for pharmacists was 40.19 years (10.60). The average time (SD) since training 
for clinicians in years was 11.76 (9.48) and 13.02 (10.09) for pharmacists. The average 
time (SD) in current practice for clinicians in years was 6.25 (5.83) and 9.23 (6.75) for 
pharmacists. A t-test was performed for all the continuous variables in the demographic 
data and a significant difference was found between the groups for the time in current 
practice in years (CI- 2.55-3.01, p=0.04). 
 
Table 4.1 - Response Rate by Type of Healthcare Professional 




 Number of  
respondents 
% of respondents 
by each category 
Physicians 57 35 60% 
Physician Assistants 9 7 78% 
Resident Physicians 24 6 25% 
Nurse Practitioners 2 1 50% 




Table 4.2 - Survey Respondent Characteristics 
Variable Clinicians Pharmacists P Value 
Total       43       36  
Sex N % N       %  0.95 
Male 17 39.53 % 14 38.88 %  
Female 26 60.46 % 22 61.11 %  
Age(mean)[std dev] (43.23) [9.52] (40.19) [10.60] 0.18 
>_25 to <35 10 23.23 % 13 36.11 %  
>_ 35 to <45 13 30.23 % 14 38.88 %  
>_ 45 20 46.51 % 9 25 %  




(11.76) [9.48] (13.02) [10.09] 0.56 
<1 6 13.95 % 0   
1 >10 15 34.88% 16 44.44 %  
10 >20 12 33.33% 11 30.55 %  
>_ 20 10 23.25 % 7 19.44 %  
Time in current practice 
setting, Yrs(mean)[Std 
dev] 
(6.25) [5.83] (9.23) [6.75] 0.04 
<1 8 18.60% 1 2.77 %  
1>5 14 32.55% 12 33.33 %  
5>10 10 23.25 % 9 25 %  






4.3 Clinicians’ and Pharmacists’ Reported Frequencies of Use of the 
Different Sources for New Drug Information 
      The top sources used for seeking drug information among clinicians and pharmacists 
were (1) drug information databases such as Micromedex and ePocrates, (2) hand-held 
devices such as PDAs, (3) other online sources such as Google and Wikipedia and (4) 
medical literature indices such as PubMed, Medline, and CINAHL. This was determined 
by the frequencies at which the healthcare professionals reported using each source ‘At 
least daily.’ 
4.3.1. Drug Information Databases (Micromedex, ePocrates) 
In Figure 4.1, the X – axis represents the type of health care professional and the 
Y- axis the percentage of reported use of drug information database for seeking drug 
information. 
About 78% of the pharmacists reported the use of drug information databases at 
least daily. Eleven percent of the pharmacists reported to use it weekly and another 11% 
used it monthly. Clinicians’ use of drug information databases was more dispersed. 47% 
of the clinicians reported to use it at least daily, 16% of the clinicians reported to use it 
weekly, 14%  of the clinicians reported to use it monthly, 7% of the clinicians used it 
once in 6 months, 3% of the clinicians used it yearly and 10% of the clinicians used it 
less than once a year. 




Figure 4.1- Reported Frequencies of Use of Drug Information Database for Seeking 
      Drug Information by Clinicians and Pharmacists 
study reported the use of drug information databases more frequently for drug 
information than clinicians within this study. 
4.3.2. Personal Digital Assistants (PDAs) 
In Figure 4.2, the X- axis represents the type of health care professional and the 
Y- axis the percentage of reported use of Personal Digital Assistants (PDAs) for seeking 
drug information. About 23% of the clinicians reported the use of PDAs at least daily as 
compared to 11% of the pharmacists. Sixteen percent of the clinicians and 17% of the 
pharmacists used it weekly. Approximately 9% of the clinicians and 5 % of the 
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Figure 4.2- Reported Frequencies of Use of Personal Digital Assistants  
                         (PDAs) for  Seeking Drug Information by 
                                        Clinicans and Pharmacists 
six months. Two percent of the clinicians and 3% of the pharmacists used PDAs yearly 
and 44% of the clinicians and 58% of the pharmacists used PDAs less than once a year. 
      Thus, from Figure 4.2 it can be concluded that the clinicians within this study 
reported the use of PDAs more frequently than pharmacists within this study to obtain 
drug information. From Figure 4.2, it was very striking to notice that a lot of clinicians 
and pharmacists reported using PDAs less frequently that yearly to search for drug 
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that clinicians (55%) and pharmacists (88%) greater than or equal to 45 years of age were 
less likely to use PDA. This is represented in Figures 4.3 and 4.4. 
       In Figures 4.3 and 4.4, the X- Axis represents age in years and the Y- Axis 
represents the percentage of reported use of Personal Digital Assistants(PDAs) by 
type of health care professional. About 40% of the clinicians and 45% of the 
pharmacists between the age group of greater than and equal to 25 years but less  
 
Figure 4.3– Clinicians Reported Frequency of Use of PDAs by  
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Figure 4.4 – Pharmacists Reported Frequency of Use of PDAs by Age 
                                        as a Source of Drug Information 
than 35 years reported using the PDAs less than once a year. Approximately 38% of the 
clinicians and 62% of the pharmacists between the age groups of greater than and equal 
to 35 years but less than 45 years reported using the PDAs less than once a year. Among 
clinicians and pharmacists greater than and equal to 45 years of age, about 55% and 89%, 
respectively, reported the use of PDAs less than once a year to obtain drug information. 
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     Age (years) 
28 
 
4.3.3. Electronic Sources (ES) (Google, Wikipedia) 
In Figure 4.5, the X- axis represents the type of health care professional and the 
Y- axis the percentage of reported use of Electronic Sources (ES) for seeking drug 
information. The reported use of ES for drug information was somewhat evenly spread 
out between the clinicians and pharmacists. Eighteen percent of the clinicians  and 28% 
of the pharmacists reported the use of ES at least daily, 30% of the clinicians and 33% of 
the pharmacists reported the use of ES weekly, 23% of the clinicians and 19% of the 
pharmacists reported the use of ES monthly, 14% of the clinicians and 11% of the 
pharmacists reported the use of ES once in 6 months, 2% of the clinicians reported the 
use of ES yearly and 9% of the clinicians reported the use of ES less than once a year for 
drug information. 
Thus, from Figure 4.5, it can be seen that clinicians and pharmacists within this 
study used electronic sources (Google, Wikipedia) to the same extent to obtain drug 
information. 
4.3.4. Medical Literature Indices (MLI) 
 (PubMed, MEDLINEPlus, CINHAL) 
In Figure 4.6, the X- axis represents the type of health care professional and the 
Y- axis the percentage of reported use of Medical Literature Indices (MLI) for seeking 
drug information. Clinicians (14%) reported the use of MLI at least daily, 30% of the 
clinicians used MLI weekly, 21% reported the use of MLI monthly, 5% reported the use 




Note- Electronic Sources- Google, Wikipedia 
Figure 4.5 - Reported Frequencies of Use of Electronic Sources for Seeking Drug                    























Less frequent than 
yearly 
Yearly 
Once in 6 months 
Monthly 
Weekly 
At least daily 
Health care professionals reported frequencies of use of  Electronic 



















Note- Medicial literature indicies- PubMed, MEDLINEPlus, CINAHL 
Figure 4.6 - Reported Frequencies of Use of Medical Literature Indicies for Seeking  
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of MLI less than once a year. Among pharmacists, the reported use of MLI was 
somewhat dispersed. Nineteen percent of the pharmacists reported the use of MLI at least 
daily and another 19% reported the use of it weekly. Thirty–six percent of the 
pharmacists reported the use of MLI monthly, 14% of the pharmacists reported the use of 
MLI once in 6 months, 3% of the pharmacist reported the use of MLI yearly and about 
5% of the pharmacists reported the use of  MLI less than once a year. 
Thus, from Figure 4.6, it is reasonable to conclude that pharmacists within this 
study reported the use of medical literature indices to seek drug information on a daily 
basis while clinicians’ within this study reported the use of it weekly to seek drug 
information. 
4.4 Information Sources Used by Healthcare Professionals, 
Ranked by the  Percentage of Respondents Who 
Used Them “At Least Daily” 
        Ranks for the different resources reported to be used by clinicians and 
pharmacists are shown in Table 4.3. This table was compiled from tables in Appendix 
B, using the reported percentage frequency from the “At Least Daily” column for 
resources used by the health care professionals’. Clinicians and pharmacists both 
ranked drug information database as their first choice for seeking new drug 
information (47%, 78%, respectively). Clinicians ranked PDAs (23%) as the second 
most frequently used source while Pharmacists ranked electronic sources (28%) as the 




Table 4.3 - Information Sources Used by Healthcare Professionals, 
        Ranked by the Percentage of Respondents  
       Who Used Them “At Least Daily” 
 







Electronic Sources 3 2 
Medical literature indices 4 3 
Journals 5 4 
Books 6 6 
Drug Information Service 6 5 
Note: Pharmaceutical Sales representatives, Medical Science liaisons’, Request from Pharmaceutical Manufactures and Product 













5.1 Reported Sources Used by Healthcare Professionals  
to Seek New Drug Information 
Seeking drug information is a complex process that integrates written and oral 
sources of information. Because of the exponential increase in medical knowledge and 
the broad scope of family practice, it has become essential that health care professionals 
stay abreast of the latest finding in the drug world to improve patient care.  
Results from this study indicate that most clinicians (47%) within the community 
clinics reported the use of drug information databases (micromedex, ePocrates) to seek 
drug information followed by PDAs (23%) to seek drug information. Among the 23% of 
the clinicians who reported using PDAs to seek drug information, about 60 % of the 
clinicians greater than age 45 years reported using the PDA less than once a year. A 
possible reason for this could be the lack of skill required to use the PDA to retrieve the 
required drug information or the investment involved with the instrument and its 
associated applications required for seeking drug information. Another reason could be 
resistance to change on the part of the older health care professionals in the way they seek 
drug information. Books and journals were reported to be used lesser among clinicians to 
seek drug information. Colleagues were hardly used as a source of information among
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clinicians. The use of the Internet to seek drug information was also reported by 17% of 
the clinicians. In contrast to these study findings, literature2,3,4,6,9 indicated that among 
clinicians, there was a fairly high usage of books, journals, meeting with colleagues and 
PDAs, in this order, to seek drug information. This difference in the sources used to seek 
drug information could be most likely due to growth in the technological field. Post- 
Internet boom and PDA invention, growth in the technological field has improved the 
access to different drug information resources at the point of care. Physicians have 
become more confident in being able to use the Internet and PDAs, making retrieval of 
drug information easy and less time consuming. This reasoning is supported from 
previous study findings. A study by Bennett et al. that focuses on the use of  the Internet, 
concluded that health care professionals use of the Internet as a source to seek drug 
information has increased from 4.4 times/month in 2001 to 8.6 times/month in 2003. 14 
Another recent study that focuses on the clinical use of a hand-held drug reference 
guide15 showed that physicians felt this technology saved time to get the drug information 
at the point of care, improved patient safety by reducing medical errors and could be 
incorporated into their work flow. Both the studies mentioned above did not allow for 
comparisons with other sources of information or health care professionals. Thus, results 
from this study as reported by clinicians indicate that when given a choice between 
traditional sources of information and modern sources of information, they reported  
preferring using modern sources of drug information.  
      Pharmacists, on the other hand, differed slightly from clinicians in the way they seek 
drug information. Most pharmacists (78%) indicated that they used drug information 
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databases to seek drug information followed by the use of medical literature indices 
(19%). Books and journals were among the least frequently used resource to seek drug 
information. This finding differs from literature 27, 28, 29 which suggest that pharmacists 
prefer using text books as their primary source of drug information. The possible reasons 
for this difference could be because pharmacists’ drug information needs are very 
specific, making it easier for them to retrieve the required information from the vast body 
of literature. The other reason could be improved access to computers at the work place 
making it more feasible for them to find the required information and the short time 
frame since their graduation. Almost half the pharmacists within this study population 
had graduated within the last 10 years, during which using the Internet to seek drug 
information was at its peak. As a result of which, most were trained and more confident 
in using modern technology to seek the required drug information. Previous literature 
findings focus on one type of information source and health care professional and do not 
allow comparisons. Thus, results from this study as reported by pharmacists indicate that 
when given a option between traditional sources of information and modern sources of 
information, they reported preferring using modern sources of drug information.  
      Findings from this small-scale study tries to fill the gap in literature by comparing 
clinicians and pharmacists and the different types of information sources preferred when 
given a choice between traditional and modern sources. It provides an insight into how 
health care professionals within the community clinics are reporting a shift towards the 
use of modern technology in seeking drug information. This timely access to drug 




5.2 Limitations of the Study 
     There were a few limitations to the study that may have prevented acquisition 
of better information. The study included only primary care providers within the 
University of Utah Community Clinics that constrained the sample size. Thus, the first 
limitation of the study was small sample size (154). The second limitation was the short 
time frame of 52 days. This limited the number of follow-ups that could be done for the 
study. The third limitation was the low response rate. Only 85 (55%) of the total 185 who 
were mailed the survey responded. An increase in the time frame for the study could have 
increased the response rate.  The fourth limitation of the study was the exclusion of 
resident physicians. The reasons for the exclusion of resident physicians were (1) they 
were not full time employees at the clinics, (2) they did rotations among different clinics 
and specialties, (3) their time in current practice was less than 3 years and all of them 
were in training and (4) they were visited too often by sales representatives (2-3 times a 
week. This could be due to the fact that they rotated at different clinics that have different 
restrictions and their part-time employee status and (5) small sample size (6). This 
exclusion of resident physicians from the study further decreased the response rate. The 
fifth limitation of the study was presence of effect modifiers which were not controlled 
for. In this study, age and the compound effect of age and time in practice were the effect 
modifiers. In retrospect, the use of subgroup analysis would have allowed us to control 
for these variables, enabling better interpretation of the results. The sixth limitation of the 
study was related to the pharmacist group in which 9 other pharmacists from specialty 
practice clinic sites were included. The reason behind not excluding them was that they 
were still a part of the community clinics, except that their functions were highly 
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specialized. The seventh limitation of the study was the grouping of physician assistants 
and nurse practitioners with the physician group. The reasons to group them together 
were (1) similarity in functions performed with the physicians, (2) full-time employee 
status which made them more aware of the clinic rules, (3) similar average time in current 
practice and (4) small sample size for physicians assistants (7) and nurse practitioners (1). 
This grouping resulted in another limitation of preventing in-between group differences 
from being captured.  Finally, the results of this study are somewhat limited because the 
sampling frame included physicians associated with a University medical center.  
Physicians in nonacademic settings may have different information-seeking behaviors. 
5.3 Future Work 
In future work, to improve the generalizability, (i) the study could expand the 
sampling frame to include physicians, nurse practitioners, and pharmacists practicing in 
nonacademic settings or (ii) carry out a similar study in India in a similar community 
clinic setting with general practitioners, nurses and pharmacists to find out how these 







       With new and advancing digital systems, it is important to know health care 
professionals’ preferences and drug information-seeking behaviors. This survey was 
initiated to study how health care professionals were seeking drug information and to find 
out descriptively if there were any differences in their information seeking behaviors. 
Results from this study indicate that there were slight differences in the way clinicians 
and pharmacists sought drug information. Drug information databases were reported to 
be the most frequently used by clinicians and pharmacists to seek drug information. 
PDAs were reported to be the next most frequently used source by physicians while 
among pharmacists, it was medical literature indices (PubMed, MEDLINEPlus, 
CINHAL) followed by use of electronic sources like Google and Wikipedia among both 
the groups.  
Thus, from the results of this study, it is reasonable to conclude that the way in 
which health care professionals are seeking drug information is undergoing a change. 
When clinicians and pharmacists are presented with a wide range of choices for seeking 
drug information, modern improved technology is preferred to seek the required 
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information as compared to the traditional sources of information like books and 
colleagues. The use of the Internet and PDAs as a medical information resource has taken 
the place of books and colleagues that were traditionally used as an important source of 
drug information. Institutional investment in providing the PDAs to their health care 
professionals, the required applications searching drug information for a nominal fee in 
addition to appropriate training in using the different applications can help health care 
professionals to improve patient care. For training purposes, the medical librarians could 
play a vital role in bridging the gap between the health care professionals and improved 
technology. The librarians could provide appropriate training to health care professionals 
to use the different drug information resources and create awareness about the available 
resources. The use of the Internet and PDAs to seek drug information should be 
incorporated into the residency curriculum to help health care professionals use this 
technology to their benefit. The impact of this investment could help the future 
generation of health care professionals to seek suitable drug information related to 
specific patient care within a matter of seconds. It could help clinicians peruse more drug 
information needs per patient. From a research stand point, it would provide more data on 
the way health care professionals seek drug information, making comparative studies 
possible across a broader spectrum of informational sources. It could help reduce the 
number of medical errors due to timely access of drug information via the PDAs or 
Internet.  
This understanding of health care professionals’ information needs with the 
community clinics can help the institution design suitable drug education programs 
specific to clinicians’ and pharmacists’ needs, ultimately improving patient care. 
APPENDIX A 
QUESTIONNAIRE 
Dear Clinic Provider, 
 
This survey is being conducted by Asha Krishnaraj, a graduate student in the University 
of Utah Department Pharmacotherapy, as a thesis project with the help of collaborators 
from the Department of Pharmacotherapy and School of Medicine including Diana I. 
Brixner, RPh, PhD, Joanne LaFleur, PharmD, MSPH, Xiangyang Ye, MS, and Liz Joy, 
MD, MPH. 
 
With this survey, we hope to determine how you and other healthcare professionals seek 
new drug information in community clinics in the University of Utah Health Care 
System. We also hope to find some ways that pharmaceutical companies can improve 
the way drug information is disseminated to these clinics. We know that many 
community clinics have policies that restrict access of sale representatives to clinicians, 
which may be eliminating a potentially important source of drug information. 
 
Information obtained from this survey will be kept strictly anonymous. All collected 
information will be kept strictly confidential in a password protected file. Only the 
investigators would have access to it. 
 
This survey should take only about 5-7 minutes to complete. The survey is available for 
20 days to complete from the time that you received my email. The results will be 
compiled by the end of April. 
 
I thank you in advance for participating and we will provide you a copy of the results. 
We will also be pleased to present the results to your clinic in return for your 
participation.  
  
  This questionnaire is anonymous.   Contact this questionnaire's administrator. E-survey 
technology provided by MBM at University of Utah.   Your suggestions are welcome.
 































2.  What is your age in years ?  *  
 
 










4.  How many years  has it been since you completed your training, including either 




5.  How many years have you been in your current practice ?  *  
 
*= Required  
  
 
This questionnaire is anonymous.   Contact this questionnaire's administrator.  












6.  What is the location of your primary practice site ? (Please select the best one. If you 











































Other (please specify)     
 
 
*= Required  
  
 
This questionnaire is anonymous.   Contact this questionnaire's administrator.  

















              Instructions to change answers for matrix questions 
 
To change your answer for a particular choice selected, click the button that 
corresponds to the correct choice.  
  
 
7.  How often do you use the following sources of information listed below for making 
clinical decisions?  
  At least Daily  Weekly  Monthly  
once in 6 





Library references such as 
books (harrison)        
Journals  
      
The University of Utah Drug 
Information Service        
Pharmaceutical sales 
representatives        
Medical Science Liaisons  
      
Request from pharmaceutical 
manufacturers        
Product Websites  
      
Personal digital assistance 
(PDA)        
Medical literature indices 
such as PubMed, 
MEDLINEPlus and CINAHL  
      
 Drug information database 
such as Micromedex, 
epocrates  
      
Other electronic sources such 
as Google and  Wikipedia        
Other ( specified below in 







8.  If any other source is used to obtain new drug information please specify ? 
 
Rate them on the frequency scale provided in the above question ?  ( Question 
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number 7)  
 




9.  How often do you consult other health care professionals to obtain new drug 
information for clinical decision making ? 
  At least daily  Weekly  Monthly  
Once in 






      
Physician assistant  
      
Resident physician  
      
Nurse practitioners  
      
Pharmacists  
      
Other health care 
professionals        
*= Required  
 
 
10.  In the past year, how often have you interacted with a pharmaceutical sales 
representative ?  
 
































11.  What is your view on the importance of pharmaceutical sales representatives in 
























View on the importance of 
pharmaceutical sales 
representatives in obtaining 
new drug information for 
clinical decisions  
     
 
12.  Please indicate how would you rate the following aspects of new drug information 
provided by pharmaceutical sales representatives on a scale of 1 to 5 ? (1 = highest, 5 
= lowest) 








   5  
Quality of information 
provided       
Depth of information provided  
     
Accuracy of information 
provided       
Your acceptance on 
information provided       
*= Required  
 
13.  Would you consider the new drug information provided by pharmaceutical 
companies to be more valuable if it was given by a professional from your field 









14.  Please explain why you answered question 13 (above) the way you 
did?  
   
*= Required  
  
 
This questionnaire is anonymous.   Contact this questionnaire's administrator.  






*= Required  
 
15.  Which of the following  policies are allowed at the clinics with respect to sales 
representatives ? 
 
Please select all that apply at your primary practice site that appropriately completes 
the sentence that begins with  
 
Sales representatives are allowed .....  
(Make between 1 and 9 selections)  
 




































Other restrictions (Please specify)     
 
 
*= Required  
  
 
This questionnaire is anonymous.   Contact this questionnaire's administrator.  




16.  Please indicate your perception about the impact of these policies on clinical care on a 


















      
5  
Sales representatives are 
allowed only if they have an 
appointment  
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Sales representatives are 
allowed only for one on one 
presentations  
     
Sales representatives are 
allowed only for group 
presentations  
     
Sales representatives are 
allowed only if they do not 
bring meals  
     
Sales representatives are 
allowed only if they bring 
meals  
     
Sales representatives are 
allowed to have open access to 
clinicians  
     
Sales representatives are not 
allowed any access to 
clinicians  
     
Sales representatives are 
allowed to give gifts less than 
100$  
     
Other restrictions (specified 
above in Question number 
15)  
     
*= Required  
  
 
This questionnaire is anonymous.   Contact this questionnaire's administrator.  
E-survey technology provided by MBM at University of Utah.   Your suggestions are 
welcome. 
  
*= Required  
17.  Please provide any comments about the impact of these restrictions on clinical care  
   




18.  What are some of the common barriers for obtaining new drug information in the 
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absence of sales representatives on a scale of 1 to 5? (1- Highly common barrier, 5- 






















Not enough time  
     
Insufficient computer 
technology skills       
Limited literature evaluation 
skills       
Inadequate access to 
information sources at work       
Other (specified below in 
Question number 19 )       
 
19.  If other barriers exists to clinicians for obtaining new drug information in the 
absence of sales representatives please specify ? 
 
Rate them on a scale of 1 to 5 provided in the above question ? (question number 
18)  
 
Other (please specify and rate them )     
 
 
*= Required  
  
This questionnaire is anonymous.   Contact this questionnaire's administrator.  






20.  In the absence of sale representatives, what other information sources can 
pharmaceutical companies use to provide new drug information on a scale of 1 to 5 
















 5  
Email updates  
     
Mailed fliers  
     
Online webinars  
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Medical science liaisons 
providing new drug 
information  
     
Conference calls from 
pharmaceutical companies       
Free access to new drug 
dossiers that outline new drug 
information  
     
The provision of internet links 
to web sites that provide new 
drug information  
     
DVD  
     
Continuing education  
     
Other (specified below in 
question number 21)       
 
21.  If other ( please specify) 
 
Rate them on a scale of 1 to 5 provided in the above question ,Question number 20) 
 




22.  What kind of new drug information would you like to get from pharmaceutical 
companies that would enable you to make better clinical decisions on a scale of 1 to 5 


















General information about 
disease states and disease state 
management, including 
practice guidelines  
     
Specific information about 
clinical trials related to a 
specific drug  
     
Specific information about 
drug-drug interactions       
Specific information on the 
mode of administration       
Specific information about the 
dosage of the drug       
Specific information about the 
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possible side effects of the 
new drug  
Specific information about 
drug safety       
Specific information about 
drug efficacy       
Other ( specified below in 
question 23)       
 
23.  If other please specify ?  
 
Rate them on a scale of 1 to 5 provided in the above question. (Question number 
22)  
 
Other ( Please Specify )  
    
 
 
*= Required  
  
 
This questionnaire is anonymous.   Contact this questionnaire's administrator.  
E-survey technology provided by MBM at University of Utah.   Your suggestions are 
welcome.  
*= Required 
24.  Please indicate your belief about the influence of drug detailing by pharmaceutical 
representatives on health care professionals ?  
  Positive  Neutral  Negative  
The influence is  
   
*= Required  
 









26.  Please comment on the impact of "Restricted access of sales representatives to 
health care professional' has had on the way you seek new drug information either 
positive or negative?  
   





This questionnaire is anonymous.   Contact this questionnaire's administrator.  
E-survey technology provided by MBM at University of Utah.   Your suggestions are 
welcome. 
 
   Drug Information Sources Questionnaire  Confirmation Page  
 
You have reached the end. You can use the Previous button to go back and review or 
change your responses, or you can click the Submit Final button to submit your 
responses.  





This questionnaire is anonymous.   Contact this questionnaire's administrator.  











   Drug Information Sources Questionnaire  Completion Page  
 
Thank you for completing this questionnaire.  
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You can now close this window.  
  
 
This questionnaire is anonymous.   Contact this questionnaire's administrator.  




Table B.1- Clinicians’ Reported Frequencies of Use of the Different Sources to Seek 









once  a 
Year 
Missing 
 N % N % N % N % N % N % N % 
Library 
References 
1 2 10 23 11 25 11 25 1 2 8 19 1 2 
Journals 2 5 15 54 22 51 4 9 0  0  0  
U of U DI 
services 
0  1 2 11 25 8 19 2 5 18 42 2 5 
Pharmaceutical 
Sales Reps 
0  0  1 2 8 19 3 7 29 68 5 12 
Medical Science 
Liaisons 




0  0  0  3 7 1 2 37 86 2 5 
Product 
Websites 
0  0  4 9 11 25 6 14 20 46 2 5 








20 46 7 16 6 14 3 7 1 2 4 9 2 5 
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Weekly Monthly Once in 6 
Months 
Yearly Less than 
once  a 
Year 
Missing 






8 19 13 30 10 23 6 14 1 2 4 9 1 2 
Other 4 9 4 9 6 14 1 2 1 2 6 14 21 49 
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Table B.2- Pharmacists’ Reported Frequencies of Use of the Different 









once  a 
Year 
Missing 
 N % N % N % N % N % N % N % 
Library 
References 
0 2 7 19 6 17 11 30 1 3 9 25 2 5 
Journals 4 11 10 28 8 22 9 25 1 3 3 8 1 3 
U of U DI 
services 
3 8 3 8 9 25 16 44 1 3 4 11 0  
Pharmaceutical 
Sales Reps 
0  1 3 3 8 7 19 3 8 21 58 1 3 
Medical Science 
Liaisons 




0  0  1 3 11 30 8 22 15 42 1 3 
Product 
Websites 
0  5 14 16 44 8 22 3 8 4 11 0  








28 78 4 11 4 11 0  0  0  0  
Other Electronic 
Sources 
10 28 12 33 7 19 4 11 0  0  0  
Other 0  2 5 3 8 1 3 0  5 14 23 64 
APPENDIX C 
DEFINITIONS 
1. Health care professionals- For this study health care professionals (HCP) are referred 
to as clinicians and pharmacists collectively. 
2. Drug information databases (Micromedex, ePocrates) - It is defined as a database that 
includes information on thousands of prescriptions and over-the-counter medication, 
including information on dosing, potential side effects, interactions with food and/or 
other drugs, drug reviews, emergency treatment protocols and information on 
alternative and herbal medicines. Examples of these databases include Micromedex 
and Epocrates. 
3. Medical literature indices- It refers to articles in books and journals dedicated to the 
field of medicine. They are online libraries containing massive collections of medical 
journals. Examples include PubMed, MEDLINE Plus and CINAHL. They provide 
easy access to extensive information about drugs, clinical trials, drug safety and the 
latest health news. 
4. Electronic sources- For this study, they were defined as search engines used to find 
medical information. Examples: Google, Wikipedia. 
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5. General practitioners- They are physicians but in different countries they are known 
as general practitioners.(GP) 
6. Utah Health Research Network (UHRN) - The Utah Heath Research Network is a 
network that helps in promoting research within the University of Utah between 
providers and researcher. It overlooks studies carried out within the community 
clinics and acts as an interface between the principal investigator and the health care 
professionals. This research network helps in coordinating meetings with providers to 
ensure participation. UHRN provides a platform to begin research involving 
providers and researcher. It begins with submitting the research proposal with its 
aims, objectives, study groups and implications. All the community clinics within the 
University of Utah are under the cover of the network with a centralized email system 
among the clinicians for effective communications.34
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